Suzhou Genhouse Bio Co., Ltd.

This is the first human study of an experimental drug called GH2616 for women with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find the safest dose and understand how the body processes the drug. Researchers will enroll 126 parti…